VNBTrust National Association lessened its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 4.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 89,600 shares of the financial services provider’s stock after selling 4,625 shares during the quarter. Trupanion makes up about 1.5% of VNBTrust National Association’s investment portfolio, making the stock its 16th largest position. VNBTrust National Association owned 0.30% of Trupanion worth $2,623,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Wells Fargo & Company MN raised its position in shares of Trupanion by 13.5% during the second quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock worth $252,000 after acquiring an additional 1,342 shares during the last quarter. California Public Employees Retirement System grew its stake in shares of Trupanion by 3.7% during the second quarter. California Public Employees Retirement System now owns 42,200 shares of the financial services provider’s stock worth $944,000 after purchasing an additional 1,500 shares during the period. Alliancebernstein L.P. grew its stake in shares of Trupanion by 11.4% during the second quarter. Alliancebernstein L.P. now owns 18,600 shares of the financial services provider’s stock worth $416,000 after purchasing an additional 1,900 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Trupanion by 3.2% during the third quarter. Bank of New York Mellon Corp now owns 77,182 shares of the financial services provider’s stock worth $2,038,000 after purchasing an additional 2,382 shares during the period. Finally, Grand Jean Capital Management Inc. grew its stake in shares of Trupanion by 1.5% during the second quarter. Grand Jean Capital Management Inc. now owns 269,289 shares of the financial services provider’s stock worth $6,027,000 after purchasing an additional 4,105 shares during the period. Institutional investors and hedge funds own 63.25% of the company’s stock.
Trupanion, Inc. (TRUP) traded up $0.16 during mid-day trading on Thursday, reaching $34.09. The company’s stock had a trading volume of 174,500 shares, compared to its average volume of 229,155. Trupanion, Inc. has a fifty-two week low of $13.71 and a fifty-two week high of $35.07. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.87 and a quick ratio of 1.87. The firm has a market cap of $1,019.25, a P/E ratio of -378.74 and a beta of 0.14.
Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, November 2nd. The financial services provider reported $0.01 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.04. Trupanion had a negative net margin of 1.05% and a negative return on equity of 7.41%. The firm had revenue of $63.12 million for the quarter, compared to analysts’ expectations of $61.44 million. During the same quarter last year, the firm earned ($0.06) EPS. The company’s quarterly revenue was up 30.5% compared to the same quarter last year. equities research analysts expect that Trupanion, Inc. will post -0.04 earnings per share for the current year.
In other Trupanion news, Director Murray B. Low sold 3,000 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $31.14, for a total transaction of $93,420.00. Following the sale, the director now owns 197,281 shares of the company’s stock, valued at approximately $6,143,330.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Tricia Plouf sold 1,000 shares of the business’s stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $32.11, for a total transaction of $32,110.00. Following the sale, the chief financial officer now directly owns 14,000 shares in the company, valued at approximately $449,540. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,039 shares of company stock worth $661,393. Insiders own 31.24% of the company’s stock.
Several research firms have recently weighed in on TRUP. Zacks Investment Research upgraded Trupanion from a “hold” rating to a “buy” rating and set a $29.00 target price on the stock in a report on Wednesday, October 4th. BidaskClub upgraded Trupanion from a “sell” rating to a “hold” rating in a research note on Tuesday, December 12th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $35.00 price target (up from $29.00) on shares of Trupanion in a research note on Tuesday, October 31st. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. Trupanion presently has an average rating of “Buy” and an average price target of $28.83.
ILLEGAL ACTIVITY WARNING: This piece was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/18/vnbtrust-national-association-reduces-position-in-trupanion-inc-trup.html.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.